C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2011
08/18/2011	US20110200987 Compositions and methods for modifying cellular properties
08/18/2011	US20110200638 Bacterial vaccine
08/18/2011	US20110200629 Tumor antigen peptide and use thereof
08/18/2011	US20110200628 Chimeric Proteins that Induce Effects Directed Against Viruses
08/18/2011	US20110200626 Iqgap3 epitope peptides and vaccines containing the same
08/18/2011	US20110200624 Novel peptides for use in transfection
08/18/2011	US20110200622 Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor
08/18/2011	US20110200608 Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
08/18/2011	US20110200605 Polypeptides and use thereof
08/18/2011	US20110200602 Antibodies to egfl7 and methods for their use
08/18/2011	US20110200596 Monovalent antibody fragments useful as therapeutics
08/18/2011	US20110200594 Functionalized polypeptides
08/18/2011	US20110200593 Combination Therapy for the Treatment of Ocular Neovascular Disorders
08/18/2011	US20110200590 Antibodies Directed Against the Myelin Basic Protein Recognising an Epitope of CD64 and Their Use as Immunosuppressants
08/18/2011	US20110200585 Cd127 binding proteins
08/18/2011	US20110200580 Methods of treatment and prevention of diet-induced obesity and sequelae thereof
08/18/2011	US20110200576 Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
08/18/2011	US20110200567 Methods and compositions for the treatment of lung diseases and disorders
08/18/2011	US20110200562 Chimeric Cytokine of IL-7 and Beta Chain of HGF and Methods of Use
08/18/2011	DE102010014680A1 Zellen, Nukleinsäuren, Enzyme und deren Verwendung sowie Verfahren zur Herstellung von Sophorolipiden Cells, nucleic acids, enzymes and their use and to processes for the preparation of sophorolipids
08/18/2011	DE102004045186B4 Liposomen, die die intrazelluläre Penetration von Wirkstofen stimulieren, deren Verwendung zur Herstellung von topischen pharmazeutischen bzw. kosmetischen Zusammensetzungen, die diese Liposomen enthalten sowie ein Screening-Verfahren zum Auffinden von Substanzen zur Stimulierung der intrazellulären Penetration Liposomes, which stimulate the intracellular penetration of Wirkstofen, their use for the preparation of topical pharmaceutical and cosmetic compositions containing these liposomes as well as a screening method for finding substances for stimulating the intracellular penetration
08/18/2011	CA2827049A1 Dermatological pharmaceutical composition suitable for oligonucleotides
08/18/2011	CA2814762A1 Oligonucleotides relating to clostridium difficile genes encoding toxin b, toxin a, or binary toxin
08/18/2011	CA2789517A1 Use of the lactosylceramide synthase isoform b1,4galt-v as a biomarker for cancer
08/18/2011	CA2789454A1 Method for acquiring genetically identical gamete from lethal fish haploid-derived germ cell via germ line chimera
08/18/2011	CA2789425A1 Digital analyte analysis
08/18/2011	CA2789416A1 Novel uses
08/18/2011	CA2789310A1 Radioactive metal-labeled anti-cadherin antibody
08/18/2011	CA2788850A1 Targeted genomic modification with partially single-stranded donor molecules
08/18/2011	CA2788535A1 Method for producing recombinant virus
08/18/2011	CA2788400A1 Antibodies against cxcr4
08/18/2011	CA2788387A1 Carbohydrate binding modules with reduced binding to lignin
08/18/2011	CA2787990A1 Nucleic acid complexes
08/18/2011	CA2786835A1 Method for the production of ad26 adenoviral vectors
08/18/2011	CA2785529A1 Compositions and methods for the detection of small rnas
08/17/2011	EP2357582A1 Methods and devices for identifying patterns in biological systems
08/17/2011	EP2357478A2 Diagnosis of disease
08/17/2011	EP2357256A2 Assay for methylation in the GST-Pi gene
08/17/2011	EP2357255A2 Assay for methylation in the GST-Pi gene
08/17/2011	EP2357247A1 Method for producing poly-3-hydroxyalkanoate
08/17/2011	EP2357244A2 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells.
08/17/2011	EP2357243A2 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells.
08/17/2011	EP2357242A1 Signal transduction stress-related proteins and method of use in plants
08/17/2011	EP2357241A1 Collagen producing plants and methods of generating and using same
08/17/2011	EP2357240A1 Plant centromere compositions
08/17/2011	EP2357239A1 Methods and means for a selectable marker system in plants
08/17/2011	EP2357238A2 Compositions and methods for regulation of tumor necrosis factor-alpha
08/17/2011	EP2357237A1 A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
08/17/2011	EP2357236A2 compositions and methods for therapy and diagnosis of cancer
08/17/2011	EP2357235A2 Compositions and methods for therapy and diagnosis of cancer
08/17/2011	EP2357234A2 Compositions and methods for therapy and diagnosis of cancer
08/17/2011	EP2357233A2 Compositions and methods for therapy and diagnosis of cancer
08/17/2011	EP2357232A2 Compositions and methods for therapy and diagnosis of cancer
08/17/2011	EP2357231A2 Stabilized immune modulatory RNA (SIMRA) compounds
08/17/2011	EP2357230A1 Modification of RNA resulting in improved transcript stability and translation efficiency
08/17/2011	EP2357229A1 Hydroxylase gene and use thereof
08/17/2011	EP2357228A1 Novel fructosyl peptide oxidase
08/17/2011	EP2357226A1 Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity
08/17/2011	EP2357225A1 Thermostable primase/DNA polymerase of the Thermococcus nautilus 30/1 plasmid pTN2 and its applications
08/17/2011	EP2357224A1 Method for isolating the dna of the avian infectious laryngotracheitis virus for pcr analysis
08/17/2011	EP2357222A1 Scyllo-inositol-producing cell and scyllo-inositol production method using said cells
08/17/2011	EP2357202A1 Targeted binding agents directed to Upar and uses thereof
08/17/2011	EP2357201A1 Anti-P-selectin antibodies
08/17/2011	EP2357200A1 Human antibodies that bind human TNFalpha
08/17/2011	EP2357199A1 Antibody against n-terminal region of -chain of hemoglobin
08/17/2011	EP2357198A1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
08/17/2011	EP2357193A1 Human GIL-19/AE289 proteins and polynucleotides encoding same
08/17/2011	EP2357192A1 Human endokine alpha and methods of use
08/17/2011	EP2357189A2 AAV virions with decreased immunoreactivity and uses therefor
08/17/2011	EP2357187A1 Molecules with extended half-lives, compositions and uses thereof
08/17/2011	EP2357010A1 Method of increasing the function of an AAV vector
08/17/2011	EP2357008A1 Albumin fusion proteins
08/17/2011	EP2357004A1 NRG-2 nucleic acid molecules, polypeptides and diagnostic and therapeutical methods
08/17/2011	EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation
08/17/2011	EP2357000A1 Mucosal and systemic immunizations with alphavirus replicon particles
08/17/2011	EP2356994A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/17/2011	EP2356901A1 Induction of gene expression in arthropods
08/17/2011	EP2356899A1 Plant having resistance to multiple diseases and method for production thereof
08/17/2011	EP2356259A2 Products and processes for multiplex nucleic acid identification
08/17/2011	EP2356258A2 Methods and compositions of molecular profiling for disease diagnostics
08/17/2011	EP2356251A1 Teneurin and cancer
08/17/2011	EP2356244A1 Transformation of sugarcane
08/17/2011	EP2356243A1 Genetic loci associated with cell wall digestibility in maize
08/17/2011	EP2356242A2 Methods for using positively and negatively selectable genes in a filamentous fungal cell
08/17/2011	EP2356241A1 Artificial chromosome vector
08/17/2011	EP2356240A2 Novel synthetic expression vehicle
08/17/2011	EP2356239A2 Gi-igg intron for enhanced anti-igf1 r expression
08/17/2011	EP2356238A2 Nurr1 interacting protein (nuip)
08/17/2011	EP2356237A1 A thermotolerant non-k12 escherichia coli phytase and its production
08/17/2011	EP2356236A1 siRNA COMPOSITIONS AND METHODS FOR POTENTLY INHIBITING VIRAL INFECTION
08/17/2011	EP2356235A1 E. coli mediated gene silencing of beta-catenin
08/17/2011	EP2356234A2 Dosage of oligonucleotides suitable for the treatment of tumors
08/17/2011	EP2356233A2 Method for collecting oral mucosa skin cells and/or cell fragments
08/17/2011	EP2356232A1 Method for purification of nucleic acids, particularly from fixed tissue
08/17/2011	EP2356231A2 Compatible display vector systems
08/17/2011	EP2356230A1 Cancer related gene, lgn/gpsm2
08/17/2011	EP2356229A1 Method for preparing high-throughput sequenceable dna from individual plaques of phages presenting peptides
08/17/2011	EP2356211A1 Improved production of riboflavin
08/17/2011	EP2356210A2 Automated system for the lysis of microorganisms in a sample, and for the extraction and purification of the nucleic acids of said microorganisms for analysis
08/17/2011	EP2356154A1 Engineered antibodies with reduced immunogenicity and methods of making

1 ... 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 ... 4023